EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Multifocal Insulinoma as the Unique Presenting Feature of Multiple Endocrine Neoplasia Type 1 in an Adolescent

Alison Murray, Sonia Priscila Rodas Marquez, Mansa Krishnamurthy, Oscar Lopez-Nunez, Juan P Gurria, Andrew T Trout, Susan Almazan, Krishnamallika Mutyala, Gabriella Grisotti, Amy Shah, Jonathan Howell

Hormone Research in Paediatrics · 2024

DOI: 10.1159/000538211 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Alison Murray und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 1, Insulinoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant inherited disorder defined by the presence of two of the following endocrinopathies: primary hyperparathyroidism, anterior pituitary tumors, and duodenopancreatic neuroendocrine tumors (NETs). NETs, which can secrete hormones including insulin, gastrin, and glucagon, among others, are common in patients with MEN1 and are a major cause of morbidity and premature death. NETs are more common later in life, with very few cases described in children. Here, we describe a unique case of an adolescent with multifocal pancreatic NETs as the single presenting feature of MEN1. Case Presentation: A 13-year-old healthy male presented with severe weakness, altered mental status, and syncope in the setting of a venous blood glucose (BG) of 36 mg/dL. Workup showed an elevated insulin level (14 μIU/mL) when BG was 39 mg/dL with positive response to glucagon, concerning for hyperinsulinism. Diazoxide and chlorothiazide were started but not well tolerated secondary to emesis. Three suspected NETs were identified by magnetic resonance imaging and 68-Ga DOTATATE PET-CT imaging, including the largest, a 2.1 cm mass in the pancreatic head. A fourth mass in the pancreatic tail was identified via intraoperative ultrasound. All lesions were successfully enucleated and excised, and glucose levels normalized off diazoxide by post-op day 2. While the primary lesion stained for insulin and somatostatin by immunofluorescence (IF), consistent with his clinical presentation, the additional tumors expressed glucagon, somatostatin, pancreatic polypeptide, and chromogranin A but were negative for insulin. Genetic testing confirmed a pathogenic heterozygous mutation in MEN1 (c.969C>A, p.Tyr323). He had no other signs of MEN-associated comorbidities on screening. Discussion/Conclusion: This case demonstrates that young patients with MEN1 can present with multifocal NETs. These NETs may have polyhormonal expression patterns despite a clinical presentation consistent with one primary hormone. Our patient had clinical symptoms and laboratory evaluation consistent with an insulinoma but was found to have four NETs, each with different IF staining patterns. Advanced preoperative and intraoperative imaging is important to identify and treat all present NETs. Moreover, serum hormone levels pre- and posttreatment could help evaluate whether NETs are actively secreting hormones into the bloodstream or simply expressing them within the pancreas. Finally, this case highlights the importance of genetic testing for MEN1 in all young patients with insulinomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Endocrine Neoplasia Type 1InsulinomaPancreatic NeoplasmsHumansMaleAdolescent

Stichwörter der Autor:innen

Endocrine tumorHyperinsulinismHypoglycemiaMultiple endocrine neoplasia type 1

Autor:innen und Institutionen

  • Department of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Pediatric Endocrinology, Huntsville Hospital, Huntsville, Alabama, USA.
  • Department of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of General and Thoracic Pediatric Surgery, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Radiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Endocrinology, Dayton Children's Hospital, Dayton, Ohio, USA.

Förderung

  • NIEHS NIH HHS

Zitieren

APA

Murray, A., Rodas Marquez, S. P., Krishnamurthy, M., Lopez-Nunez, O., Gurria, J. P., Trout, A. T., Almazan, S., Mutyala, K., Grisotti, G., Shah, A., & Howell, J. (2024). Multifocal Insulinoma as the Unique Presenting Feature of Multiple Endocrine Neoplasia Type 1 in an Adolescent. Hormone Research in Paediatrics. https://doi.org/10.1159/000538211

Vancouver

Murray A, Rodas Marquez SP, Krishnamurthy M, Lopez-Nunez O, Gurria JP, Trout AT, et al. Multifocal Insulinoma as the Unique Presenting Feature of Multiple Endocrine Neoplasia Type 1 in an Adolescent. Hormone Research in Paediatrics. 2024. doi:10.1159/000538211

BibTeX
@article{Murray2024,
  author = {Murray, Alison and Rodas Marquez, Sonia Priscila and Krishnamurthy, Mansa and Lopez-Nunez, Oscar and Gurria, Juan P and Trout, Andrew T and Almazan, Susan and Mutyala, Krishnamallika and Grisotti, Gabriella and Shah, Amy and Howell, Jonathan},
  title = {Multifocal Insulinoma as the Unique Presenting Feature of Multiple Endocrine Neoplasia Type 1 in an Adolescent},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  doi = {10.1159/000538211}
}
Kostenlos starten →